VI
TRML

Versor Investments’s Tourmaline Bio TRML Stock Holding History

Versor Investments’s Portfolio TRML Stock Details TRML Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-217,221
Closed -$10.4M – 789
2025
Q3 		$10.4M Buy
+217,221
New +$6.02M 1.91% 8

Versor Investments's TRML Position: Q4 2025 in Review

Versor Investments sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 217,221 shares — an estimated $10.4M sold.

Versor Investments first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $10.4M in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

  • Versor Investments reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
  • Versor Investments sold 217,221 Tourmaline Bio shares in Q4 2025, an estimated $10.4M.
  • Versor Investments first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
  • Versor Investments's Tourmaline Bio position peaked at $10.4M in Q3 2025.
  • 0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Versor Investments's 13F filing for Q4 2025, filed 4 Feb 2026.